Cimetidine and its synthesis method
By preparing hollow carbon spheres and forming pores in the stomach, the problem of short retention time of cimetidine sustained-release tablets in the gastrointestinal tract was solved, achieving slow release and high bioavailability of cimetidine in the stomach, and a long duration of efficacy.
Patent Information
- Application Number
- CN202311786032.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-25
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-12-25
AI Technical Summary
Existing cimetidine extended-release tablets have a short residence time in the gastrointestinal tract, resulting in incomplete drug release and reduced bioavailability. The question is how to achieve slow release in the stomach to prolong the duration of efficacy and reduce the frequency of administration.
Hollow carbon spheres are used as a carrier. They are formed by incorporating calcium carbonate and high-concentration carbon dioxide. Then, they are treated with dilute hydrochloric acid to form pores. Cimetidine and excipients are mixed to form cimetidine microspheres, which can achieve floating and slow release in the stomach.
Cimetidine microspheres remain in the stomach for a long time, resulting in sustained drug release, high bioavailability, few side effects, long duration of efficacy, and rapid action on the affected area, reducing the onset time.
Smart Images

Figure BDA0004625196870000091 
Figure BDA0004625196870000101
Abstract
Description
Technical Field
[0001] This invention belongs to the field of drug preparation, specifically relating to a cimetidine and its synthesis method. Background Technology
[0002] Cimetidine is an H2 receptor antagonist that competitively binds to H2 receptors on parietal cells, significantly inhibiting basal gastric acid secretion as well as gastric acid secretion induced by various factors such as histamine, pentagastrin, insulin, and food. It is currently widely used to treat duodenal ulcers, gastric ulcers, and upper gastrointestinal bleeding. Cimetidine is available in various dosage forms, including injections, immediate-release tablets, chewable tablets, capsules, emulsions, and sustained-release tablets. While traditional sustained-release tablets can reduce the frequency of administration and maintain a more stable blood drug concentration, they have the physiological limitation of a shorter gastrointestinal retention time. For cimetidine, which is mainly absorbed in the upper digestive tract, the drug may not be fully released before passing through its site of action, leading to reduced bioavailability. Therefore, finding a way to slowly release the drug in the stomach to prolong its duration of action, reduce the frequency of administration, and improve drug utilization is of significant practical importance. Summary of the Invention
[0003] This invention mainly provides a method for synthesizing cimetidine, which has a longer retention time in the stomach. The technical solution is as follows:
[0004] A cimetidine is prepared by the following steps: calcium carbonate is added during the preparation of hollow carbon spheres to form hollow carbon spheres containing calcium carbonate; then an acid is added in an amount less than the amount of calcium carbonate contained to remove part of the calcium carbonate, and then the acid is mixed with cimetidine and excipients to form cimetidine microspheres.
[0005] A method for synthesizing the above-mentioned cimetidine includes the following steps:
[0006] (1) Add sodium dodecyl sulfate to a 1 mol / L glucose solution, mix thoroughly, and react at 170℃ for 5-8 h to obtain the reaction solution;
[0007] (2) Add calcium carbonate to the reaction solution and react at 180°C for 2-5 hours. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor.
[0008] (3) After replacing the gas in the reaction system with nitrogen, the hollow carbon sphere precursor is calcined at 800-850°C for 2 hours in a high concentration of CO2 atmosphere to obtain carbon spheres containing calcium carbonate.
[0009] (4) Place the carbon spheres containing calcium carbonate in a dilute hydrochloric acid solution with a pH of 3 to 5 and let them stand for 5 to 30 minutes. After thorough washing, disperse them evenly in a cimetidine mixture. Shake the mixture at room temperature until the organic solvent evaporates. After washing and drying, cimetidine microspheres are obtained.
[0010] Furthermore, the sodium dodecyl sulfate in step (1) has a content of 0.01 to 0.05 mol / L in the glucose solution.
[0011] Furthermore, the molar ratio of calcium carbonate in step (2) to glucose in step (1) is 1:10-20.
[0012] Furthermore, the concentration of the CO2 atmosphere in step (3) is 85-100%.
[0013] Furthermore, the molar ratio of hydrochloric acid in the dilute hydrochloric acid in step (4) to calcium carbonate in step (2) is 1:5 to 10.
[0014] Furthermore, in step (4), the weight ratio of cimetidine to calcium carbonate-containing carbon spheres in the cimetidine mixture is 1:1.5 to 5.
[0015] Furthermore, the preparation of the cimetidine mixture in step (4) includes the following steps: placing cimetidine in anhydrous ethanol to obtain a 1.5 mmol / L cimetidine ethanol solution, then adding 5 to 20 times the weight of the drug as excipients, and then adding Tween-80 to make the content of Tween-80 5 to 10 g / L. After thorough mixing, the cimetidine mixture is obtained.
[0016] Furthermore, the excipients include one or more of microcrystalline cellulose, ethyl cellulose, hydroxypropyl methylcellulose, and carboxymethyl cellulose.
[0017] By adopting the above scheme, the method of the present invention has the following advantages:
[0018] 1. The cimetidine microspheres of the present invention are hollow, can float in gastric juice, have a long retention time in the stomach, continuously release the drug in the stomach, have a long duration of efficacy, and act directly on the stomach, with high bioavailability and few side effects.
[0019] 2. In the preparation process of hollow carbon spheres, a small amount of calcium carbonate is added. After ingestion, the gastric acid reacts with the calcium carbonate, resulting in a brief, rapid, and uniform release of the drug in the early stage, which quickly acts on the affected area and shortens the onset time of the drug.
[0020] 3. The high concentration of carbon dioxide in this invention can stabilize the carbonization process while reducing the consumption of calcium carbonate.
[0021] 4. This invention uses dilute hydrochloric acid to consume a small amount of calcium carbonate, which creates pores in the part of the sphere that comes into contact with the dilute hydrochloric acid. This facilitates the entry of cimetidine and excipients into the hollow sphere, thereby improving the sustained-release effect of the drug and prolonging the duration of drug action.
[0022] 5. The carbon balls, calcium carbonate, and other substances in this invention have no impact on health, the raw materials are relatively simple, the production cost is low, and the product quality is higher. Detailed Implementation
[0023] The technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0024] Example 1
[0025] (1) Prepare a 1 mol / L glucose solution from 1 mol of glucose, add 0.3 mol of sodium dodecyl sulfate, mix thoroughly, and react at 170℃ for 6 h to obtain the reaction solution;
[0026] (2) Add 0.1 mol of calcium carbonate to the reaction solution and react at 180°C for 3 h. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor.
[0027] (3) The hollow carbon sphere precursor was calcined at 800°C for 2 hours in a 100% CO2 atmosphere to obtain carbon spheres containing calcium carbonate.
[0028] (4) Place 0.3 times the weight of the carbon spheres containing calcium carbonate in anhydrous ethanol to prepare a 1.5 mmol / L cimetidine ethanol solution. Then add 10 times the weight of the drug in microcrystalline cellulose, and then add Tween-80 to make the content of Tween-80 8 g / L. After mixing thoroughly, a cimetidine mixture is obtained.
[0029] (5) Using 0.01 mol of hydrochloric acid, prepare a dilute hydrochloric acid solution with a pH of 3 to 5. Place the carbon spheres containing calcium carbonate in the dilute hydrochloric acid solution and let them stand for 30 min. After thorough washing, they are evenly dispersed in the cimetidine mixture. The reaction is shaken at room temperature until the organic solvent evaporates. After washing and drying, cimetidine microspheres are obtained.
[0030] Example 2
[0031] (1) Prepare a 1 mol / L glucose solution from 1 mol of glucose, add 0.3 mol of sodium dodecyl sulfate, mix thoroughly, and react at 170℃ for 6 h to obtain the reaction solution;
[0032] (2) Add 0.05 mol of calcium carbonate to the reaction solution and react at 180°C for 3 h. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor.
[0033] (3) The hollow carbon sphere precursor was calcined at 800°C for 2 hours in a 100% CO2 atmosphere to obtain carbon spheres containing calcium carbonate.
[0034] (4) Place 0.3 times the weight of the carbon spheres containing calcium carbonate in anhydrous ethanol to prepare a 1.5 mmol / L cimetidine ethanol solution. Then add 10 times the weight of the drug in microcrystalline cellulose, and then add Tween-80 to make the content of Tween-80 8 g / L. After mixing thoroughly, a cimetidine mixture is obtained.
[0035] (5) Using 0.01 mol of hydrochloric acid, prepare a dilute hydrochloric acid solution with a pH of 3 to 5. Place the carbon spheres containing calcium carbonate in the dilute hydrochloric acid solution and let them stand for 30 min. After thorough washing, they are evenly dispersed in the cimetidine mixture. The reaction is shaken at room temperature until the organic solvent evaporates. After washing and drying, cimetidine microspheres are obtained.
[0036] Example 3
[0037] (1) Prepare a 1 mol / L glucose solution from 1 mol of glucose, add 0.3 mol of sodium dodecyl sulfate, mix thoroughly, and react at 170℃ for 6 h to obtain the reaction solution;
[0038] (2) Add 0.1 mol of calcium carbonate to the reaction solution and react at 180°C for 3 h. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor.
[0039] (3) After replacing the gas in the reaction system with nitrogen, the hollow carbon sphere precursor is calcined at 800°C for 2 hours in an atmosphere of 85% CO2 to obtain carbon spheres containing calcium carbonate.
[0040] (4) Place 0.3 times the weight of the carbon spheres containing calcium carbonate in anhydrous ethanol to prepare a 1.5 mmol / L cimetidine ethanol solution. Then add 10 times the weight of the drug in microcrystalline cellulose, and then add Tween-80 to make the content of Tween-80 8 g / L. After mixing thoroughly, a cimetidine mixture is obtained.
[0041] (5) Using 0.01 mol of hydrochloric acid, prepare a dilute hydrochloric acid solution with a pH of 3 to 5. Place the carbon spheres containing calcium carbonate in the dilute hydrochloric acid solution and let them stand for 30 min. After thorough washing, they are evenly dispersed in the cimetidine mixture. The reaction is shaken at room temperature until the organic solvent evaporates. After washing and drying, cimetidine microspheres are obtained.
[0042] Example 4
[0043] (1) Prepare a 1 mol / L glucose solution from 1 mol of glucose, add 0.3 mol of sodium dodecyl sulfate, mix thoroughly, and react at 170℃ for 6 h to obtain the reaction solution;
[0044] (2) Add 0.1 mol of calcium carbonate to the reaction solution and react at 180°C for 3 h. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor.
[0045] (3) The hollow carbon sphere precursor was calcined at 850°C for 2 hours in a 100% CO2 atmosphere to obtain carbon spheres containing calcium carbonate.
[0046] (4) Place 0.3 times the weight of the carbon spheres containing calcium carbonate in anhydrous ethanol to prepare a 1.5 mmol / L cimetidine ethanol solution. Then add 10 times the weight of the drug in microcrystalline cellulose, and then add Tween-80 to make the content of Tween-80 8 g / L. After mixing thoroughly, a cimetidine mixture is obtained.
[0047] (5) Using 0.01 mol of hydrochloric acid, prepare a dilute hydrochloric acid solution with a pH of 3 to 5. Place the carbon spheres containing calcium carbonate in the dilute hydrochloric acid solution and let them stand for 30 min. After thorough washing, they are evenly dispersed in the cimetidine mixture. The reaction is shaken at room temperature until the organic solvent evaporates. After washing and drying, cimetidine microspheres are obtained.
[0048] Example 5
[0049] (1) Prepare a 1 mol / L glucose solution from 1 mol of glucose, add 0.3 mol of sodium dodecyl sulfate, mix thoroughly, and react at 170℃ for 6 h to obtain the reaction solution;
[0050] (2) Add 0.1 mol of calcium carbonate to the reaction solution and react at 180°C for 3 h. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor.
[0051] (3) The hollow carbon sphere precursor was calcined at 800°C for 2 hours in a 100% CO2 atmosphere to obtain carbon spheres containing calcium carbonate.
[0052] (4) Place 0.6 times the weight of the carbon spheres containing calcium carbonate in anhydrous ethanol to prepare a 1.5 mmol / L cimetidine ethanol solution. Then add 10 times the weight of the drug in microcrystalline cellulose, and then add Tween-80 to make the content of Tween-80 8 g / L. After mixing thoroughly, a cimetidine mixture is obtained.
[0053] (5) Using 0.01 mol of hydrochloric acid, prepare a dilute hydrochloric acid solution with a pH of 3 to 5. Place the carbon spheres containing calcium carbonate in the dilute hydrochloric acid solution and let them stand for 30 min. After thorough washing, they are evenly dispersed in the cimetidine mixture. The reaction is shaken at room temperature until the organic solvent evaporates. After washing and drying, cimetidine microspheres are obtained.
[0054] Example 6
[0055] (1) Prepare a 1 mol / L glucose solution from 1 mol of glucose, add 0.3 mol of sodium dodecyl sulfate, mix thoroughly, and react at 170℃ for 6 h to obtain the reaction solution;
[0056] (2) Add 0.1 mol of calcium carbonate to the reaction solution and react at 180°C for 3 h. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor.
[0057] (3) The hollow carbon sphere precursor was calcined at 800°C for 2 hours in a 100% CO2 atmosphere to obtain carbon spheres containing calcium carbonate.
[0058] (4) Place 0.2 times the weight of the carbon spheres containing calcium carbonate in anhydrous ethanol to prepare a 1.5 mmol / L cimetidine ethanol solution. Then add 10 times the weight of the drug in microcrystalline cellulose, and then add Tween-80 to make the content of Tween-80 8 g / L. After mixing thoroughly, a cimetidine mixture is obtained.
[0059] (5) Using 0.01 mol of hydrochloric acid, prepare a dilute hydrochloric acid solution with a pH of 3 to 5. Place the carbon spheres containing calcium carbonate in the dilute hydrochloric acid solution and let them stand for 5 minutes. After thorough washing, disperse them evenly in the cimetidine mixture. Shake the mixture at room temperature until the organic solvent evaporates. After washing and drying, obtain cimetidine microspheres.
[0060] Example 7
[0061] (1) Prepare a 1 mol / L glucose solution from 1 mol of glucose, add 0.3 mol of sodium dodecyl sulfate, mix thoroughly, and react at 170℃ for 6 h to obtain the reaction solution;
[0062] (2) Add 0.1 mol of calcium carbonate to the reaction solution and react at 180°C for 3 h. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor.
[0063] (3) The hollow carbon sphere precursor was calcined at 800-850°C for 2 hours in a 100% CO2 atmosphere to obtain carbon spheres containing calcium carbonate.
[0064] (4) Place 0.3 times the weight of the carbon spheres containing calcium carbonate in anhydrous ethanol to prepare a 1.5 mmol / L cimetidine ethanol solution. Then add 10 times the weight of the drug in microcrystalline cellulose, and then add Tween-80 to make the content of Tween-80 8 g / L. After mixing thoroughly, a cimetidine mixture is obtained.
[0065] (5) Using 0.01 mol of hydrochloric acid, prepare a dilute hydrochloric acid solution with a pH of 3 to 5. Place the carbon spheres containing calcium carbonate in the dilute hydrochloric acid solution and let them stand for 5 minutes. After thorough washing, disperse them evenly in the cimetidine mixture. Shake the mixture at room temperature until the organic solvent evaporates. After washing and drying, obtain cimetidine microspheres.
[0066] Preparation and testing of samples for the example:
[0067] Concentration determination: 3.0 g of the finished product from each example was ground into a fine powder and accurately weighed. It was diluted to 100 mL with anhydrous ethanol and sonicated for 10 min before filtration. 2 mL of the filtrate was accurately measured and placed in a 50 mL volumetric flask. After dilution to volume, the absorbance was measured at 218 nm using UV-Vis spectrophotometry. The cimetidine content in the sustained-release microspheres was calculated. Three samples were prepared for each example, and the average value of the results from each example was taken.
[0068] w(drug loading) = m(drug in microspheres) / m(microspheres) × 100%, w(encapsulation efficiency) = m(drug in microspheres) / m(drug input) × 100%.
[0069] Dissolution determination: Dissolution was determined according to the 2020 edition of the Chinese Pharmacopoeia. At 37°C, 900 mL of artificial gastric fluid was used as the dissolution medium, and the rotation speed was 100 rpm. Samples were taken at 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h, 10 h, and 12 h. The dissolution of each embodiment was determined according to the concentration determination method described above.
[0070] Test results:
[0071]
[0072]
[0073] As shown in the table above, each embodiment of this application has a high drug loading capacity and a high encapsulation rate. The drugs all have a significant release process in the early stage, while also ensuring a uniform and slow release of the drugs in the later stage.
[0074] In Example 2, the amount of calcium carbonate added was lower, resulting in a reduced drug loading capacity. This may be due to smaller pores created by the later reaction with hydrochloric acid, leading to a relatively smaller amount of drug entering the sphere and reducing the initial rapid drug release effect. In Example 3, the low carbon dioxide atmosphere concentration resulted in more calcium carbonate decomposition during carbonization, creating more pores in the carbon spheres and increasing drug loading. In Example 4, the higher carbonization temperature also caused more calcium carbonate decomposition, increasing drug loading, but slightly reducing the encapsulation efficiency. This may be due to greater calcium carbonate loss, affecting the integrity of the spheres and hindering drug encapsulation. In Examples 3 and 4, greater calcium carbonate loss occurred during carbonization, resulting in a rapid initial drug release, but a poorer sustained-release effect in the later stages. Examples 5 and 6 corresponded to different dosages; higher dosages increased drug loading, and vice versa. However, increased dosages also posed challenges to the encapsulation efficiency, requiring a comprehensive approach to formulation selection. Example 7 shows that the acid treatment time for calcium carbonate-containing carbon spheres is shorter, resulting in fewer pores, a reduced drug loading, and a decrease in the initial rapid release of the drug.
[0075] For those skilled in the art, various other corresponding changes and modifications can be made based on the technical solutions and concepts described above, and all such changes and modifications should fall within the protection scope of the claims of this invention.
Claims
1. A cimetidine microsphere, characterized in that, The following steps were used to prepare the hollow carbon spheres: calcium carbonate was added during the preparation of the hollow carbon spheres to form hollow carbon spheres containing calcium carbonate; then, an acid of less than the amount of calcium carbonate was added to remove some of the calcium carbonate, and then the mixture was mixed with cimetidine and excipients to form cimetidine microspheres; the specific operation steps are as follows: (1) Add sodium dodecyl sulfate to a 1 mol / L glucose solution, mix thoroughly, and react at 170℃ for 5-8 h to obtain the reaction solution; (2) Add calcium carbonate to the reaction solution and react at 180°C for 2-5 hours. Filter the crude product and wash it several times with anhydrous ethanol and distilled water to obtain the hollow carbon sphere precursor. (3) After replacing the gas in the reaction system with nitrogen, the hollow carbon sphere precursor is calcined at 800-850°C for 2 hours in a CO2 atmosphere with a concentration of 85-100% to obtain carbon spheres containing calcium carbonate. (4) Place the carbon spheres containing calcium carbonate in a dilute hydrochloric acid solution with a pH of 3 to 5 and let them stand for 5 to 30 minutes. After washing thoroughly, disperse them evenly in the cimetidine mixture. Shake the mixture at room temperature until the organic solvent evaporates. After washing and drying, obtain cimetidine microspheres. In step (2), the molar ratio of calcium carbonate to glucose in step (1) is 1:10~20; in step (4), the molar ratio of hydrochloric acid to calcium carbonate in dilute hydrochloric acid is 1:5~10; and in step (4), the weight ratio of cimetidine to carbon spheres containing calcium carbonate in the cimetidine mixture is 1:1.5~5.
2. The cimetidine microspheres according to claim 1, characterized in that, The sodium dodecyl sulfate in step (1) has a content of 0.01~0.05 mol / L in the glucose solution.
3. The cimetidine microspheres according to claim 1, characterized in that, The preparation of the cimetidine mixture in step (4) includes the following steps: Cimetidine is placed in anhydrous ethanol to obtain a 1.5 mmol / L cimetidine ethanol solution, and then 5 to 20 times the weight of the drug excipients are added. Then Tween-80 is added so that the content of Tween-80 is 5 to 10 g / L. After thorough mixing, the cimetidine mixture is obtained.
4. The cimetidine microspheres according to claim 1, characterized in that, The excipients include one or more of microcrystalline cellulose, ethyl cellulose, hydroxypropyl methylcellulose, and carboxymethyl cellulose.
Citation Information
Patent Citations
Bioadhesive type hollow microsphere and preparation method thereof
CN104367555A
Low-temperature rapid preparation method of hollow capsule-shaped calcium carbonate
CN112850767A
